Synthetic peptide corresponding to a region within N terminal amino acids 135-165 of Human FAM91A1, conjugated to KLH.
WB: Neuro 2a cell line lysates
IHC-P: Human cervix carcinoma tissue
Flow Cyt: HeLa cells
Shipped at 4°C. Store at 4°C (up to 6 months). Store at -20°C long term.
Preservative: 0.09% Sodium Azide
Concentration information loading...
Immunogen affinity purified
ab103969 is purified through a protein A column, followed by peptide affinity purification.
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/100 - 1/500. Predicted molecular weight: 94 kDa.
1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
1/10 - 1/50.
ab171870 - Rabbit polyclonal IgG, is suitable for use as an isotype control with this antibody.
FAM91A1 (family with sequence similarity 91, member A1) is a 94 kDa hypothetical phospho protein that is not yet characterized.
Family with sequence similarity 91 member A1 antibody
Western blot - FAM91A1 antibody (ab103969)
Anti-FAM91A1 antibody (ab103969) at 1/100 dilution + Neuro 2a cell line lysates at 35 µg
Predicted band size: 94 kDa
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - FAM91A1 antibody (ab103969)
ab103969, at a 1/50 dilution, staining FAM91A1 in formalin fixed and paraffin embedded Human cervix carcinoma by Immunohistochemistry, followed by peroxidase-conjugated secondary antibody and DAB staining.
Flow Cytometry - FAM91A1 antibody (ab103969)
ab103969, at a 1/10 dilution, staining FAM91A1 in HeLa cells by Flow Cytometry (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis..
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"